title: Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib.
authors.forename: Cristina
authors.initials: C
authors.lastname: Oliveras-Ferraros
authors.forename: Sílvia
authors.initials: S
authors.lastname: Cufí
authors.forename: Tamara
authors.initials: T
authors.lastname: Sauri-Nadal
authors.forename: Sonia
authors.initials: S
authors.lastname: Del Barco
authors.forename: Begoña
authors.initials: B
authors.lastname: Martin-Castillo
authors.forename: Alejandro
authors.initials: A
authors.lastname: Vazquez-Martin
authors.forename: Javier A
authors.initials: JA
authors.lastname: Menendez
mesh_terms: D015107:4-Butyrolactone / Q000031:analogs & derivatives*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000378:metabolism*; D064429:Fatty Acid Synthases / Q000378:metabolism*; D005260:Female; D006801:Humans; D011799:Quinazolines / Q000494:pharmacology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
chemical_list: D015107:4-Butyrolactone; D000970:Antineoplastic Agents; D064429:Fatty Acid Synthases; D011799:Quinazolines; D018719:Erb-b2 Receptor Tyrosine Kinases